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a b s t r a c t
To evaluate the effects of aerobic training and stretching on serum levels of serotonin (5HT) 
and its main metabolite 5-hydroxindolacetic acid (5HIAA).
Twenty-two women with FM were randomized into one of two exercise modalities (aero-
bic walking exercise or stretching exercise) to be accomplished three times a week for 20 
weeks. The serum levels of 5HT and 5HIAA were evaluated before and after the exercise 
program by high performance liquid chromatography (HPLC) with colorimetric detection.
Within group analysis (pre-post) showed that serum levels of both 5HT and 5HIAA changed 
signifi cantly in the aerobic group during the 20-week course of therapy (5HT: P = 0,03; 
5HIAA: P = 0,003). In the stretching group, however, no statistically signifi cant change was 
observed (5HT: P=0,491; 5HIAA: P=0,549). Between group statistical comparisons of labora-
tory measures disclosed that aerobic training was superior to stretching in that it signifi -
cantly increased the levels of 5HIAA (F test = 6.61; P = 0.01), but the average difference be-
tween groups on the levels of 5HT did not meet signifi cance criteria (F test = 3.42; P = 0.08).
Aerobic training increases the 5HIAA and 5HT levels and it could explain why aerobic ex-
ercise can improve symptoms in fi bromyalgia syndrome patient more than stretching ex-
ercise.
© 2013 Elsevier Editora Ltda. All rights reserved.
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Efeitos do exercício físico sobre os níveis séricos de serotonina e seu 







r e s u m o
Avaliar os efeitos do treinamento aeróbico e do alongamento sobre os níveis séricos de 
serotonina (5-HT) e seu principal metabólito ácido 5-hidroxiindolacético (5-HIAA).
Foram randomizadas 22 mulheres com fi bromialgia (FM) em uma de duas modalidades 
de exercício (exercício aeróbico de caminhada ou exercício de alongamento) a serem rea-
lizadas três vezes por semana, por 20 semanas. Os níveis séricos de 5-HT e 5-HIAA foram 
avaliados antes e após o programa de exercícios por cromatografi a líquida de alta efi ciência 
(CLAE) com detecção colorimétrica.
A análise de grupo (pré-pós) mostrou que os níveis séricos de 5-HT e 5-HIAA mudaram 
signifi cativamente no grupo aeróbico durante o período de 20 semanas de terapia (5-HT: 
p = 0,03; 5-HIAA: p = 0,003). No grupo alongamento, contudo, não foi observada qualquer 
alteração estatisticamente signifi cativa (5-HT: p = 0,491; 5-HIAA: p = 0,549). Comparações 
estatísticas das medidas de laboratório entre os grupos constataram que o treinamento 
aeróbico foi superior ao alongamento, aumentando signifi cativamente os níveis de 5-HIAA 
(teste F – 6,61; p = 0,01); porém, a diferença média entre os grupos a respeito dos níveis de 
5-HT não atendeu aos critérios de relevância (teste F = 3,42; p = 0,08).
O treinamento aeróbico aumenta os níveis de 5-HIAA e 5-HT e poderia explicar porque o 
exercício aeróbico pode melhorar os sintomas de pacientes com síndrome de fi bromialgia 
mais que o exercício de alongamento.
© 2013 Elsevier Editora Ltda. Todos os direitos reservados.
Physical exercise is a low-cost, safe, and effi cient intervention 
for the treatment of the fi bromyalgia syndrome (FM). There is 
evidence of its effi cacy not only in the reduction of pain and 
the number of tender points, but also in the improvement of 
quality of life, mood, and other psychological aspects.1,2
It is believed that all types of physical exercise are benefi -
cial, but the greatest evidence supports the benefi ts of aerobic 
training.2,3 Although it has been established over the last two 
decades that exercise is fundamental for the treatment of FM, 
the mechanisms involved remain unknown.
Based on studies with animal models, with healthy hu-
mans, and in a variety of human diseases, it appears that 
exercise acts upon many sites of pain modulation, and there-
fore, may infl uence numerous pathophysiologic mechanisms. 
For example, aerobic exercise is known to increase peripheral 
levels of beta-endorphins,4,5 to infl uence the serotonergic sys-
tem,6 to decrease sympathetic activity,7 to improve sleep,8 and 
to foster a sense of psychological well-being.9,10
Published clinical trials have demonstrated that aerobic 
conditioning is superior to stretching as an intervention to 
improve FM pain, functional capacity, and quality of life.1-3 It 
was also observed that aerobic conditioning was effi cient at 
improving emotional aspects of this disorder, while stretch-
ing offers no apparent clinical benefi t.1 One hypothesis to ex-
plain these results posits that aerobic exercise may increase 
the availability of biogenic amines such as serotonin and nor-
epinephrine to improve anxiety/depression through their ef-
fects on neuroendocrinologic mechanisms.1,11
This study aimed to evaluate the effects of aerobic train-
ing and stretching on serum levels of serotonin (5HT) and its 
main metabolite, 5-hydroxindolacetic acid (5HIAA).
Twenty-two sedentary women were sequentially selected 
according to the timing of their arrival to the rheumatology 
outpatient clinic of the Universidade Federal de São Paulo. 
They were aged between 18 and 60 years and met the 1990 
classifi cation criteria of the American College of Rheumatol-
ogy (ACR 1990).
All were randomized into one of two exercise modalities 
(aerobic walking exercise or stretching exercise) to be accom-
plished three times a week for 20 weeks. The randomization 
ratio was two patients in the aerobic exercise group for each 
person in the control group (2:1). Patients with any of the fol-
lowing were excluded: cardiorespiratory diseases which lim-
ited their physical activity, neurologic disorders, body mass 
index > 35, hypothyroidism, or any rheumatic disease. All pa-
tients were newly diagnosed and had never undergone any 
previous treatment for their FM symptoms. Only acetamino-
phen was allowed as rescue medication during the study. The 
study project was approved in the Ethics Committee of the 
Universidade Federal de São Paulo. All potential study partici-
pants were provided written information regarding each as-
pect of the study, and no study activity was undertaken with 
a subject before an informed consent was signed.
Study subjects were evaluated by a blinded investigator 
at the beginning and at the end of 20 weeks (end of the ex-
ercise program). Clinical benefi ts and improvement of their 
conditioning with the active intervention group were previ-
ously published.1 Blood samples were drawn from an arm 
vein before exercise in the beginning and at the end of the 
study. The sera were stored at -70°C until analyzed. The tubes 
containing the serum samples were number-coded in order 
to blind the laboratory personnel regarding treatment group 
and the sequence of sample collection. Analytical measure-
ments of serum 5HT and 5-HIAA were accomplished by high 
performance liquid chromatography (HPLC) with colorimetric 
detection.
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For the statistical analyses, the Statistical Package for the 
Social Sciences (SPSS), release 12.0, was used. Student’s t-test 
and paired t-test were used to compare the average concen-
trations of the metabolites (5HT and 5HIAA) from each group 
(aerobic and stretching) before and after the intervention. 
Analysis of variance for repeated measures (ANOVA) was per-
formed to compare the metabolite levels in both groups. Aver-
age differences were considered to be statistically signifi cant 
when P < 0.05.
Table 1 shows that 14 of the 22 female study subjects were 
randomized to the aerobic exercise group and eight were 
randomized to the stretching group. There was no signifi -
cant difference in demographics between the study groups at 
baseline when considering age, body mass index, pain visual 
analog scale (VAS), and quality of life.
All subjects completed the 20-week program, but two 
patients from the stretching group were excluded since not 
enough serum to perform HPLC analyses was obtained.
At baseline, there was no statistically signifi cant difference 
in the values between groups for 5HT (P = 0.71), but the initial 
5HIAA values were signifi cantly higher in the stretching exer-
cise group (P = 0.009, Table 1).
Intra-group analysis (pre/post) demonstrated that serum 
levels of both 5HT and 5HIAA changed signifi cantly in the 
aerobic group during the 20-week course of therapy (Table 1). 
In the stretching group, however, no statistically signifi cant 
change was observed (Table 1). 
Inter-group statistical comparisons of laboratory measures 
demonstrated that aerobic training was superior to stretching 
in that it signifi cantly increased the levels of 5HIAA (F test = 
6.61; P = 0.01), but the average difference between groups on 
the levels of 5HT was not statistically signifi cant (F test = 3.42; 
P = 0.08). Despite the initial difference in 5HIAA values, the 
ANOVA test showed signifi cance considering the change pre/
post between groups.
Although physical exercise is widely acknowledged as in-
dispensable for the treatment of FM, there are very few stud-
ies that have explored the mechanisms responsible for the 
achieved benefi ts. In healthy subjects, it is known that aerobic 
physical activity is capable of increasing peripheral levels of 
ß-endorphins,4 promoting a decrease in sympathetic activi-
ty,7 improving sleep,7 and facilitating psychological stability.8,9 
Regarding the monoamine-serotoninergic system, physical 
exercise can increase the sensitivity of certain types of 5HT 
receptors,12 and is also capable of increasing central6,13  and 
serum levels of 5HT. It is believed that running may elevate 
central nervous system levels of 5HT through lipolysis and 
subsequent release of free fatty acids, which dislocate trypto-
phan from serum albumin, resulting in greater availability of 
free tryptophan for 5HT synthesis.13 In addition, exercise in-
creases total platelet volume and 5HT concentration in plate-
lets, resulting in elevation of total 5HT blood levels.
It is known that serum 5HT levels are decreased in FM,14 
and that low levels of 5HT have been implicated in many as-
pects of FM pathophysiology, including imbalance of the hy-
pothalamic pituitary axis, and autonomic dysfunction that 
leads to sympathetic hyperactivity and contributes to sleep 
disorders, anxiety, Raynaud’s phenomenon, and sicca symp-
toms.15,16 The effectiveness of the available pharmacologic 
agents that increase serotonin levels in FM supports the con-
cept that this neurotransmitter is important to the pathogen-
esis of FM.17 
One of the mechanisms that contribute to the chronic 
widespread allodynia in FM is the increased pronociception 
and decreased descending inhibition or antinociception.18,19 
Serotonin is one of the neurochemicals involved in the anti-
nociception; since it is diminished in FM patients, it contrib-
utes to the chronic allodynia.14,19
The effects of physical exercise on 5HT levels in patients 
with FM have not been previously studied. However, it was 
demonstrated in patients with chronic lumbar pain that spi-
nal stabilization exercises produce an increase in serum 5HT 
levels, which could help to explain the positive results of this 
type of exercise in the management of chronic back pain.20
The present results demonstrated that the statistically 
signifi cant changes in serum levels of 5HT and 5HIAA, which 
occurred during the course of the study, could be attributed 
to aerobic exercises but not to stretching exercises. Aerobic 
training was superior to stretching in its ability to elevate 
5HIAA levels. The aerobic conditioning also showed improve-
ment in emotional and psychological aspects of the disorder, 
whereas stretching did not. In the same study subjects, FM 
pain was more responsive to aerobic activity than to stretch-
ing.1 Therefore, it appears that the serotonergic system may 
be an important modulator of the neuroendocrinological 
mechanisms through which aerobic exercise can improve 
pain, anxiety, and depression in FM.
It should be emphasized, however, that stretching cannot 
be considered a placebo intervention, since the present results 
demonstrated that this kind of exercise had some impact on 
FM pain.1 It is possible that stretching exercise has mechani-
cal benefi ts through its effects on comorbid conditions such 
as myofascial pain syndrome, which can coexist with FM in a 
substantial number of patients.21 Even mild stretching exer-
cise could mobilize fascial tissue,22,23 which may prove to be 
more important than currently perceived. Additional studies 
are needed to test these hypotheses.
When aerobic training was statistically compared with 
stretching, it was superior with regard to raising serum 5HIAA 
levels, but did not meet statistical difference for serum 5HT 
levels. It is possible that a larger sample size would show 
signifi cance. Serum levels of biogenic amines can vary with 
fasting, food ingestion, medications, alcohol ingestion, use of 
illegal drugs, hormones, and many stressful conditions.24 In 
addition, serum 5HT levels are physiologically regulated, so 
Table 1 – Baseline demographic and clinical measures 









47 ± 10 44 ± 11 P = 0.335
BMI [kg/m] 26 ± 3 28 ± 6 P = 0.186
Pain VAS 
[cm/10]
6.19 ± 1.64 6 ± 2.1 P = 0.325
FIQ 5.30 ± 1.50 4.89 ± 1.65 P = 0.303
VAS, visual analog scale; BMI, body mass index; FIQ, fi bromyalgia 
impact questionnaire.
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an increase in 5HT production might logically be expressed 
as an increase in the concentration of its stable metabolite. 
This was a pilot study, limited mainly by the small sample 
size. Despite the randomization of patients included in the 
analysis, the small sample size could explain the signifi cant 
difference in 5HIAA between patients before exercise train-
ing. In addition, the level of the study subjects’ leisure activity 
was not evaluated and could have infl uenced the results. The 
serum analyses were carried out four years after collection 
of the blood; despite cold/dark storage, sample stability could 
be a bias. It is known, however, that both 5HT and 5HIAA are 
stable if kept frozen and protected from light.25
Other studies are necessary to fully understand the im-
pact of physical exercise on central and serum levels of other 
chemical mediators, on the functioning of the autonomic ner-
vous system, on the neuroendocrine production of the HPA 
axis, and on the brain’s gray matter.
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